Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0BJ7W
|
||||
Former ID |
DIB004292
|
||||
Drug Name |
GLPG-0492
|
||||
Synonyms |
G-100192; Selective androgen receptor modulators, Galapagos; Selective androgen receptor modulators, ProSkelia; Selective androgen receptor modulators, ProStrakan; SARMs (osteoporosis), ProSkelia; SARMs (osteoporosis), ProStraken; SARMs (osteoporosis/cachexia), Galapagos
|
||||
Indication | Cachexia [ICD9: 799.4; ICD10:R64] | Preclinical | [547691] | ||
Company |
ProSkelia Pharmaceuticals SAS
|
||||
Structure |
Download2D MOL |
||||
Target and Pathway | |||||
Target(s) | Androgen receptor | Target Info | Modulator | [532281] | |
Pathway Interaction Database | Regulation of nuclear SMAD2/3 signaling | ||||
Coregulation of Androgen receptor activity | |||||
Regulation of Androgen receptor activity | |||||
Nongenotropic Androgen signaling | |||||
Regulation of nuclear beta catenin signaling and target gene transcription | |||||
FOXA1 transcription factor network | |||||
Notch-mediated HES/HEY network | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.